|
| Bivariate analysis | Multivariate analysis | ||||||
| HR | 95% IC | p-value | HR | 95% IC | p-value | |||
| Age |
|
|
|
|
|
|
|
|
| ≥60 | Ref. | . | . | . | Ref. | . | . | . |
| <20 | 1 | . | . | . | −43.014 | . | . | . |
| 20 - 30 | 1.000 | 0.112 | 8.947 | 0.069 | 2.595 | 0.926 | 4.264 | 0.002 |
| 30 - 40 | 0.300 | 0.054 | 1.669 | 0.299 | −0.054 | −1.34 | 1.232 | 0.934 |
| 40 - 50 | 0.438 | 0.092 | 2.083 | 0.926 | −0.359 | −1.539 | 0.822 | 0.551 |
| 50 - 60 | 1.083 | 0.2 | 5.872 | . | −0.506 | −1.72 | 0.708 | 0.414 |
| Clinical stage |
|
|
|
|
|
|
|
|
| Stage I | Ref. | . | . | . | Ref. | . | . | . |
| Stage II | 0.950 | 0.1475 | 6.122 | 0.957 | 1.526 | 0.66 | 2.392 | 0.001 |
| Stage III | 6.450 | 1.822 | 22.827 | 0.004 | 25.785 | 23.652 | 27.918 | 0.000 |
| Stage IV | 6.856 | 0.7212 | 65.175 | 0.094 | 28.489 | 26 | 30.977 | 0.000 |
| Previous treatment |
|
|
|
|
|
|
|
|
| None | Ref. | . | . | . | Ref. | . | . | . |
| Medical | 1.143 | 0.257 | 5.087 | 0.861 | −0.212 | −1.645 | 1.22 | 0.772 |
| Traditional | 5.061 | 1.702 | 15.047 | 0.004 | 0.304 | −0.718 | 1.327 | 0.559 |
| Conventional treatment |
|
|
|
|
|
|
|
|
| No treatment | Ref. | . | . | . | Ref. | . | . | . |
| Only surgery | 0.254 | 0.0867 | 0.7489 | 0.013 | −0.532 | −1.494 | 0.43 | 0.278 |
| Surgery and Chemotherapy | 0.125 | 0.0265 | 0.588 | 0.009 | −1.66 | −3.035 | −0.285 | 0.018 |
| Other* | 0.333 | 0.0401 | 2.7687 | 0.309 | −1.627 | −3.465 | 0.211 | 0.083 |